Cargando…
Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis – Case report
INTRODUCTION: Hypercalcaemia is most commonly a sign of primary hyperparathyroidism but can also be a sign of an active granulomatous disease. Standard treatment for primary hyperparathyroidism caused by a solitary parathyroid gland adenoma identified by localisation studies is minimally invasive fo...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318857/ https://www.ncbi.nlm.nih.gov/pubmed/34336200 http://dx.doi.org/10.1016/j.amsu.2021.102577 |
_version_ | 1783730334045569024 |
---|---|
author | Pislar, Nina Hocevar, Marko |
author_facet | Pislar, Nina Hocevar, Marko |
author_sort | Pislar, Nina |
collection | PubMed |
description | INTRODUCTION: Hypercalcaemia is most commonly a sign of primary hyperparathyroidism but can also be a sign of an active granulomatous disease. Standard treatment for primary hyperparathyroidism caused by a solitary parathyroid gland adenoma identified by localisation studies is minimally invasive focused parathyroidectomy. If unsuccessful, bilateral neck exploration is recommended. CASE PRESENTATION: We report the case of hypercalcaemia and ostheoporosis in a 63–year -old woman with a history of sarcoidosis and suspected primary hyperparathyroidism. Localisation studies for parathyroid adenoma were inconclusive due to active cervical and mediastinal granulomatous lymph nodes. Sarcoidosis was treated with corticosteroids but hypercalcaemia persisted. Focused parathyroidectomy was attempted with intraoperative parathyroid hormone measurement but an increase in parathyroid hormone levels was observed. However, with high clinical probability of a successfully removed adenoma and frozen section evaluation, we decided not to proceed with bilateral neck exploration. Serum parathyroid hormone and calcium levels dropped accordingly the following day. CLINICAL DISCUSSION: We explored all possible underlying mechanisms for persistent elevated parathyroid hormone level described in literature. CONCLUSION: We conclude that Wisconsin Criteria with intraoperative parathyroid hormone measured 20 minutes after adenoma removal should be applied in such cases. |
format | Online Article Text |
id | pubmed-8318857 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-83188572021-07-31 Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis – Case report Pislar, Nina Hocevar, Marko Ann Med Surg (Lond) Case Report INTRODUCTION: Hypercalcaemia is most commonly a sign of primary hyperparathyroidism but can also be a sign of an active granulomatous disease. Standard treatment for primary hyperparathyroidism caused by a solitary parathyroid gland adenoma identified by localisation studies is minimally invasive focused parathyroidectomy. If unsuccessful, bilateral neck exploration is recommended. CASE PRESENTATION: We report the case of hypercalcaemia and ostheoporosis in a 63–year -old woman with a history of sarcoidosis and suspected primary hyperparathyroidism. Localisation studies for parathyroid adenoma were inconclusive due to active cervical and mediastinal granulomatous lymph nodes. Sarcoidosis was treated with corticosteroids but hypercalcaemia persisted. Focused parathyroidectomy was attempted with intraoperative parathyroid hormone measurement but an increase in parathyroid hormone levels was observed. However, with high clinical probability of a successfully removed adenoma and frozen section evaluation, we decided not to proceed with bilateral neck exploration. Serum parathyroid hormone and calcium levels dropped accordingly the following day. CLINICAL DISCUSSION: We explored all possible underlying mechanisms for persistent elevated parathyroid hormone level described in literature. CONCLUSION: We conclude that Wisconsin Criteria with intraoperative parathyroid hormone measured 20 minutes after adenoma removal should be applied in such cases. Elsevier 2021-07-17 /pmc/articles/PMC8318857/ /pubmed/34336200 http://dx.doi.org/10.1016/j.amsu.2021.102577 Text en © 2021 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Pislar, Nina Hocevar, Marko Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis – Case report |
title | Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis – Case report |
title_full | Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis – Case report |
title_fullStr | Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis – Case report |
title_full_unstemmed | Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis – Case report |
title_short | Intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis – Case report |
title_sort | intraoperative parathormone increase after focused parathyroidectomy in a patient with sarcoidosis – case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318857/ https://www.ncbi.nlm.nih.gov/pubmed/34336200 http://dx.doi.org/10.1016/j.amsu.2021.102577 |
work_keys_str_mv | AT pislarnina intraoperativeparathormoneincreaseafterfocusedparathyroidectomyinapatientwithsarcoidosiscasereport AT hocevarmarko intraoperativeparathormoneincreaseafterfocusedparathyroidectomyinapatientwithsarcoidosiscasereport |